Colorectal Cancer
-
Research team awarded $9 million to study extracellular RNA in colorectal cancer
A multidisciplinary team of investigators at Vanderbilt University and Vanderbilt University Medical Center has received a program project grant from the National Cancer Institute to explore extracellular RNA in colorectal cancer. Read MoreApr 15, 2020
-
Meat intake and colorectal polyps
Red and processed meat intakes are strongly associated with increased risk of sessile serrated polyps, which are not as well studied as conventional adenomas. Read MoreMar 9, 2020
-
Colorectal cancer researchers receive SPORE funding
Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI). Read MoreAug 26, 2019
-
Fish oil and cancer prevention
Fish oil supplementation provides a modest but beneficial effect on reducing molecules associated with colorectal cancer development. Read MoreJun 24, 2019
-
Mouth health and colorectal cancer
Microbial species in the mouth could be playing a role in colorectal cancer development, according to new research from epidemiologists at VUMC. Read MoreJun 6, 2019
-
Calcium intake and colorectal cancer
Calcium intake appears to protect against colorectal cancer in individuals with certain gene variants, Vanderbilt researchers have discovered. Read MoreOct 18, 2017
-
Researchers find novel mechanism of resistance to anti-cancer drugs
Vanderbilt investigators have discovered a novel non-genetic cause of resistance to the targeted anti-cancer therapy cetuximab. Their findings, reported this week in Nature Medicine, suggest a strategy for overcoming this resistance. Read MoreOct 17, 2017
-
Fatty acids and adenoma risk
Vanderbilt researchers have found that red blood cell membrane fatty acid content is associated with risk of having colorectal adenomas, with omega-6 fatty acids increasing and omega-3 fatty acids decreasing risk. Read MoreAug 21, 2017
-
Coffey lands major NCI award to support colorectal cancer research
Vanderbilt’s Robert Coffey Jr., M.D., has received an Outstanding Investigator Award from the National Cancer Institute (NCI) — more than $6.6 million over seven years — to support studies aimed at advancing the diagnosis and treatment of colorectal cancer (CRC), a leading cancer killer. Read MoreJun 8, 2017
-
Study seeks to reverse precancerous stomach lesions
Vanderbilt University Medical Center cancer researcher James Goldenring, M.D., Ph.D., has received a two-year, $200,000 grant from the DeGregorio Family Foundation in Pleasantville, New York, to begin clinical trials of a potential approach for reversing precancerous stomach lesions. Read MoreMay 4, 2017
-
Nanobeacon lights up colon tumors
A novel fluorescent nanobeacon can distinguish normal from diseased colon tissue, potentially offering advantages for colorectal cancer screening. Read MoreMar 30, 2017
-
Study takes 3-D perspective on colorectal cancer
Despite dramatic recent advances in treatment, colorectal cancer killed more than 49,000 Americans last year, according to the National Cancer Institute, making it the second most lethal malignancy after cancers of the lung and bronchus. Read MoreMar 23, 2017
-
New target for colorectal cancer
Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development. Read MoreMar 17, 2017
-
Concert by singer Wade Hayes and friends to benefit VICC
Country music artist and cancer survivor Wade Hayes will host the second annual “Country Hits Back” benefit concert March 7 at the Franklin Theatre. The event will support vitally important cancer research at Vanderbilt-Ingram Cancer Center. Read MoreFeb 15, 2017
-
Colorectal cancer clues
Although cancers arising from different areas of the large intestine are heterogeneous, they appear to use similar important tumorigenic pathways. Read MoreJan 19, 2017
-
An Argonaute’s voyage to cancer
A genetic mutation that promotes cancer development blocks the normal sorting of a protein called “Argonaute 2.” Read MoreApr 28, 2016
-
One Million Strong event to raise awareness about colorectal cancer
Thousands of colorectal patients, families and supporters will gather in Nashville April 1 and 2 for the annual One Million Strong event to raise awareness about colorectal cancer. Read MoreMar 17, 2016
-
Study explores less invasive way to monitor colorectal cancer
Investigators at Vanderbilt University Medical Center have published research regarding an important feature of colorectal cancer (CRC) that could eventually lead to the development of non-invasive means of monitoring cancer progression. After lung cancer, CRC is the second-most lethal cancer in the United States. Read MoreFeb 18, 2016
-
Tools for exploring ‘omics’ data
The NetGestalt computing portal integrates vast amounts of data to aid users in finding biologically and clinically relevant information. Read MoreMay 18, 2015
-
Gene profile predicts metastasis
A specific gene expression profile represents a novel, biologically relevant “signature” for identifying colon cancers with high risk of metastatic recurrence, Vanderbilt researchers have found. Read MoreFeb 9, 2015